Zenith Alpha Thoracic Endovascular Graft 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 William Cook Europe 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2018-08-23
  • 사례 출판 날짜
    2018-08-23
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: william cook europe zenith alpha thoracic endovascular graft medical device manufacturer, william cook europe, has issued a medical device safety alert concerning its zenith alpha thoracic endovascular graft (catalogue identifier: all zta-devices). the manufacturer has become aware that the zenith alpha thoracic endovascular graft has been used to treat patients with thoracic aortic dissections. as per instructions for use (ifu), the graft is indicated for the endovascular treatment of patients with aneurysms or ulcers of the descending thoracic aorta having vascular morphology suitable for endovascular repair, including: iliac/femoral anatomy that is suitable for access with the required introduction systems; nonaneurysmal aortic segments (fixation sites) proximal and distal to the thoracic aneurysm or ulcer: with a length of at least 20 mm, and with a diameter measured outer-wall-to-outer-wall of no greater than 42 mm and no less than 20 mm. to emphasize best practices, the manufacturer would like to reiterate that the graft and ancillary components should be used as specified in the ifu. the ifu section 4.2 “patient selection, treatment and follow up” states that the safety and effectiveness of the zenith alpha thoracic endovascular graft and ancillary components have not been evaluated in the patient populations for dissection. users are also advised to refer to ifu section 5 for potential adverse events associated with either zenith alpha thoracic endovascular graft or the implantation procedure that may occur and/or require intervention. according to the manufacturer, no devices are needed to be returned and patients already treated for a dissection should receive standard follow up procedures. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 23 august 2018.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: William Cook Europe Zenith Alpha Thoracic Endovascular Graft
  • Manufacturer

Manufacturer